Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Hewlett Packard Enterprise Co (HPE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Hewlett Packard Enterprise Co — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Hewlett Packard Enterprise Co trades at $71.89 (market cap $94.25B). The key difference: Hewlett Packard Enterprise Co is far larger — about 20.5× Definium Therapeutics Inc. Common Shares's market cap, and Hewlett Packard Enterprise Co pays a 0.8% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hewlett Packard Enterprise Co for 33 Days on average.
| DFTX | HPE | |
|---|---|---|
Market Cap | $4.59B | $94.25B |
Volume | 2,103,937 | 16,060,854 |
Sector | Health | Technology |
52-Week High | $48.45 | $72.12 |
52-Week Low | $10.68 | $20.01 |
Typical Hold Time | 0 Days | 33 Days |
Enterprise Value | $3.55B | $108.28B |
Dividend Yield | — | 0.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
HPE stock trades at $72.115, up 2.2% today and near its all-time high, driven by strong AI infrastructure demand and a recent $1.2 billion server order from Vultr. The technical outlook is bullish, with moving averages supporting the uptrend, though RSI levels suggest overbought conditions. Fundamentally, revenue growth accelerated to $34.3 billion in 2025, but net income margin compressed to 0.16% due to higher costs, while 2026 projections show a rebound to $41.9 billion revenue and $2.8 billion net income.
The outlook remains positive given AI-driven guidance raises and analyst upgrades, but risks include execution on Juniper integration, debt levels rising to 29.48% of assets, and valuation multiples above sector averages. The stock offers growth exposure to AI infrastructure, yet investors face volatility near record highs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Hewlett Packard Enterprise Co
Hewlett Packard Enterprise is an information technology vendor that provides hardware and software to enterprises. Its primary product lines are compute servers, storage arrays, and networking equipment.
Read more on HPE →
